CYTK - Cytokinetics, Incorporated

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Income Statement
Balance Sheet
Cash Flow

Income Statement

All numbers in thousands
Total Revenue106,40728,65846,940
Cost of Revenue---
Gross Profit106,40728,65846,940
Operating Expenses
Research Development59,89746,39844,426
Selling General and Administrative27,82319,66717,268
Non Recurring---
Total Operating Expenses---
Operating Income or Loss18,687-37,407-14,754
Income from Continuing Operations
Total Other Income/Expenses Net464174108
Earnings Before Interest and Taxes19,151-37,233-14,646
Interest Expense2,698268268
Income Before Tax16,453-37,501-14,646
Income Tax Expense---
Minority Interest---
Net Income From Continuing Ops16,453-37,501-14,646
Non-recurring Events
Discontinued Operations---
Extraordinary Items---
Effect Of Accounting Changes---
Other Items---
Net Income
Net Income16,453-37,501-14,646
Preferred Stock And Other Adjustments---
Net Income Applicable To Common Shares16,453-37,501-14,646